Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Capital Expenditures came in at -$77.6 million in Q1 2026, down 4.77% year-on-year from -$81.5 million in Q1 2025, and up 25.38% on a QoQ basis from -$103.9 million in Q4 2025.
Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Capital Expenditures data on file, last reported at -$77.6 million in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 4.77% year-over-year to -$77.6 million in Q1 2026; TTM through Mar 2026 was -$301.0 million, a 3.12% decrease from a year earlier, with the FY2025 full-year figure at -$307.1 million, up 5.04% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$77.6 million, up from -$103.9 million in the prior quarter.
- Over the last five years, Capital Expenditures for STVN reached as high as -$40.7 million in Q3 2022 and fell as low as -$142.9 million in Q3 2023.
- Historically, Capital Expenditures has averaged -$83.5 million across 5 years, with a median of -$77.6 million in 2026.
- Across the five-year window, Capital Expenditures sank 250.89% in 2023 and soared 65.84% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at -$69.3 million in 2022, then fell by 27.36% to -$88.2 million in 2023, then slipped by 7.67% to -$95.0 million in 2024, then retreated by 9.42% to -$103.9 million in 2025, then rose by 25.38% to -$77.6 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$77.6 million in Q1 2026, -$103.9 million in Q4 2025, and -$54.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | -77.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.57 Mn |
| Mar 31, 2026 | -77.57 Mn |
| Dec 31, 2025 | -103.95 Mn |
| Dec 31, 2025 | -103.95 Mn |
| Sep 30, 2025 | -54.26 Mn |
| Sep 30, 2025 | -54.26 Mn |
| Jun 30, 2025 | -65.21 Mn |
| Jun 30, 2025 | -65.21 Mn |
| Mar 31, 2025 | -74.04 Mn |
| Mar 31, 2025 | -74.04 Mn |
| Dec 31, 2024 | -95.00 Mn |
| Dec 31, 2024 | -95.00 Mn |
| Sep 30, 2024 | -48.83 Mn |
| Sep 30, 2024 | -48.83 Mn |
| Jun 30, 2024 | -74.00 Mn |
| Jun 30, 2024 | -74.00 Mn |
| Mar 31, 2024 | -109.22 Mn |
| Mar 31, 2024 | -109.22 Mn |
| Dec 31, 2023 | -88.23 Mn |
| Dec 31, 2023 | -88.23 Mn |